| Tacrolimus oral bioavailability doubles with coadministration of ketoconazole LC Floren, I Bekersky, LZ Benet, Q Mekki, D Dressler, JW Lee, JP Roberts, ... Clinical Pharmacology & Therapeutics 62 (1), 41-49, 1997 | 337 | 1997 |
| Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar? U Christians, W Jacobsen, LC Floren Pharmacology & therapeutics 80 (1), 1-34, 1998 | 293 | 1998 |
| The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups LM Mancinelli, L Frassetto, LC Floren, D Dressler, S Carrier, I Bekersky, ... Clinical pharmacology & therapeutics 69 (1), 24-31, 2001 | 268 | 2001 |
| A review of interprofessional training wards: enhancing student learning and patient outcomes N Oosterom, LC Floren, O Ten Cate, HE Westerveld Medical teacher 41 (5), 547-554, 2019 | 92 | 2019 |
| Are we on the same page? Shared mental models to support clinical teamwork among health professions learners: a scoping review LC Floren, DA Donesky, E Whitaker, DM Irby, O Ten Cate, BC O’Brien Academic Medicine 93 (3), 498-509, 2018 | 54 | 2018 |
| The pharmacokinetics (PK) and safety of ceftaroline (PPI-0903) in healthy subjects receiving multiple-dose intravenous (IV) infusions Y Ge, R Redman, L Floren, S Liao, M Wikler 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2006 | 46 | 2006 |
| Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV‐1 infected liver and kidney transplant recipients L Frassetto, L Floren, B Barin, M Browne, A Wolfe, M Roland, P Stock, ... Biopharmaceutics & drug disposition 34 (8), 442-451, 2013 | 41 | 2013 |
| Nelfinavir pharmacokinetics in stable human immunodeficiency virus-positive children: Pediatric AIDS Clinical Trials Group Protocol 377 LC Floren, A Wiznia, S Hayashi, A Jayewardene, K Stanley, G Johnson, ... Pediatrics 112 (3), e220-e227, 2003 | 41 | 2003 |
| Development of an interprofessional rotation for pharmacy and medical students to perform telehealth outreach to vulnerable patients in the COVID-19 pandemic CA Bautista, I Huang, M Stebbins, LC Floren, M Wamsley, SL Youmans, ... Journal of interprofessional care 34 (5), 694-697, 2020 | 39 | 2020 |
| Single-dose pharmacokinetics (PK) of ceftaroline (PPI-0903) in healthy subjects Y Ge, L Floren, R Redman, M Wikler, S Liao 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2006 | 35 | 2006 |
| An inhibitory metabolite leads to dose-and time-dependent pharmacokinetics of (R)-N-{1-[3-(4-ethoxy-phenyl)-4-oxo-3, 4-dihydro-pyrido [2, 3-d] pyrimidin-2-yl]-ethyl}-N-pyridin … GR Tonn, SG Wong, SC Wong, MG Johnson, J Ma, R Cho, LC Floren, ... Drug metabolism and disposition 37 (3), 502-513, 2009 | 33 | 2009 |
| Pharmacokinetic interactions between cyclosporine and protease inhibitors in HIV+ subjects L Frassetto, T Thai, AM Aggarwal, P Bucher, W Jacobsen, U Christians, ... Drug metabolism and pharmacokinetics 18 (2), 114-120, 2003 | 30 | 2003 |
| Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma AI Daud, C Xu, WJ Hwu, P Urbas, S Andrews, NE Papadopoulos, ... Cancer chemotherapy and pharmacology 67, 657-666, 2011 | 27 | 2011 |
| Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma RC DeConti, AP Algazi, S Andrews, P Urbas, O Born, D Stoeckigt, ... British journal of cancer 103 (10), 1548-1553, 2010 | 27 | 2010 |
| Tamoxifen in liver disease: potential exacerbation of hepatic dysfunction LC Floren, MF Hebert, AP Venook, VC Jordan, A Cisneros, KA Somberg Annals of oncology 9 (10), 1123-1126, 1998 | 24 | 1998 |
| A phase I, double-blind, placebo-controlled study to determine the safety, tolerability, and pharmacokinetics (PK) of prolonged-infusion regimens of doripenem (DOR) in healthy … LC Floren, MA Wikler, T Kilfoil, Y Ge Program and abstracts of the 44th interscience Conference on Antimicrobial …, 2004 | 22 | 2004 |
| Sirolimus oral bioavailability increases ten‐fold with concomitant ketoconazole LC Floren, U Christians, JJ Zimmerman, L Neefe, R Schorer, D Rushworth, ... Clinical Pharmacology & Therapeutics 65 (2), 159-159, 1999 | 19 | 1999 |
| A phase 1 open-label controlled study to evaluate the safety, tolerability, and pharmacokinetics (PK) of doripenem (DOR) administered intravenously to subjects with renal … LC Floren, MA Wikler, T Kilfoil, Y Ge 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 2004 | 15 | 2004 |
| An interaction analysis model to study knowledge construction in interprofessional education: proof of concept LC Floren, O Ten Cate, DM Irby, BC O’Brien Journal of interprofessional care 35 (5), 736-743, 2021 | 14 | 2021 |
| T0903131, a selective modulator of PPAR-gamma activity, increases adiponectin levels in healthy subjects K Kersey, LC Floren, B Pendleton, MJ Stempien, J Buchanan, F Dunn Diabetes 53, A156-A156, 2004 | 13 | 2004 |
